Sverige - svenska - Läkemedelsverket (Medical Products Agency)

pfizer ab - morfinsulfat (pentahydrat) - depotgranulat till oral suspension i dospåse - 100 mg - nykockin hjälpämne; morfinsulfat (pentahydrat) 100 mg aktiv substans; xylitol hjälpämne - morfin

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

pfizer ab - morfinsulfat (pentahydrat) - depotgranulat till oral suspension i dospåse - 20 mg - nykockin hjälpämne; morfinsulfat (pentahydrat) 20 mg aktiv substans; xylitol hjälpämne - morfin

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

pfizer ab - morfinsulfat (pentahydrat) - depotgranulat till oral suspension i dospåse - 30 mg - nykockin hjälpämne; xylitol hjälpämne; morfinsulfat (pentahydrat) 30 mg aktiv substans - morfin

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

pfizer ab - morfinsulfat (pentahydrat) - depotgranulat till oral suspension i dospåse - 60 mg - xylitol hjälpämne; nykockin hjälpämne; morfinsulfat (pentahydrat) 60 mg aktiv substans - morfin

Europeiska unionen - svenska - EMA (European Medicines Agency)

accord healthcare s.l.u. - abirateronacetat - prostatiska neoplasmer - endokrin terapi - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Europeiska unionen - svenska - EMA (European Medicines Agency)

mylan ireland limited - abirateronacetat - prostatiska neoplasmer - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Europeiska unionen - svenska - EMA (European Medicines Agency)

krka, d.d., novo mesto - abirateronacetat - prostatiska neoplasmer - endokrin terapi - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

Europeiska unionen - svenska - EMA (European Medicines Agency)

axunio pharma gmbh - pirfenidon - idiopatisk lungfibros - immunsuppressiva - pirfenidone aet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).